Tuesday, May 22, 2018
Editorials

Editorial: Policy failures hurting Americans' health

Americans don't have the best heath care system in the world, just the most expensive one. The cost of pharmaceuticals is a prime example. Americans can easily pay 10 times or more what patients pay for the same drugs in some European and Asian countries. That's because the United States has an easily manipulated patent system that keeps cheap generic drugs off the market and an overreliance on the marketplace to set prices. A few changes to both would reduce costs and save lives.

The New York Times recently focused on the prevalent, chronic disease of asthma. It afflicts about 40 million people, many of them children, at a cost of $56 billion annually to treat, according to the Centers for Disease Control and Prevention. The newspaper identified one overriding reason people end up in the hospital or dead because of asthma: out-of-reach prices for the medications that control their symptoms.

There are two primary drivers of the dramatic differences in cost for asthma treatments in Europe and the United States. First, drug companies have become adept at re-patenting new versions of old drugs to stave off competition from cheaper generics. The companies make tiny alterations in a product's formula or delivery system and gain new patents. So there are no generic asthma inhalers in the United States even though they are widely available in Europe. The patent office in the United States should end its practice of granting new patents for inconsequential tweaks.

The second reason is that other governments police drug prices, either directly or indirectly, to make life-saving drugs accessible and protect taxpayers' pockets. This is in stark contrast to the hands-off approach here, the result of a Congress beholden to pharmaceutical industry lobbyists. When Medicare Part D was established, Congress prohibited the program from negotiating drug prices, which sent costs ballooning. And the United States Patient-Centered Outcomes Research Institute, which considers which treatments should be covered by federal programs, is not allowed to consider cost-effectiveness in making recommendations. These sorts of restrictions ensure that Americans and the government overpay for essential medicine. Far from letting the marketplace operate, the rules distort the market power that the government as the largest buyer of drugs should have.

There are plenty of ways to get reasonably priced medicine into people's hands and reduce costs in our health care system. All that's needed is a Congress that puts people's health above drug company influence.

Comments
Editorial: Tampa Bay House members fail to stand up to Big Sugar

Editorial: Tampa Bay House members fail to stand up to Big Sugar

Big Sugar remains king in Florida. Just three of the state’s 27 House members voted for an amendment to the farm bill late Thursday that would have started unwinding the needless government supports for sugar that gouge taxpayers. Predictably, the am...
Published: 05/18/18
Editorial: Bondi holds drug industry accountable for Florida opioid crisis

Editorial: Bondi holds drug industry accountable for Florida opioid crisis

Florida Attorney General Pam Bondi’s lawsuit against the nation’s largest drug makers and distributors marks a moment of awakening in the state’s battle to recover from the opioid crisis. In blunt, forceful language, Bondi accuses these companies of ...
Published: 05/18/18
Editorial: A sweet note for the Florida Orchestra’s violin program for at-risk kids

Editorial: A sweet note for the Florida Orchestra’s violin program for at-risk kids

This is music to the ears. Members of the Florida Orchestra will introduce at-risk students to the violin this summer at some Hillsborough recreation centers. For free.An $80,000 grant to the University Area Community Development Corp. will pay for s...
Published: 05/17/18
Updated: 05/18/18
Trump backs off China tariff threat as China pumps money into a Trump family project

Trump backs off China tariff threat as China pumps money into a Trump family project

In barely six weeks, President Donald Trump has gone from threatening to impose $150 billion in tariffs on Chinese goods to extending a lifeline to ZTE, a Chinese cell phone company that violated U.S. sanctions by doing business with Iran and North K...
Published: 05/17/18
Editorial: Activism as seniors helps put Hillsborough graduates on the right path

Editorial: Activism as seniors helps put Hillsborough graduates on the right path

Lots of teenagers are walking together this week in Hillsborough County, a practice they’ve grown accustomed to during this remarkable school year.We can only hope they keep walking for the rest of their lives.Tens of thousands of them this week are ...
Published: 05/17/18
Editorial: Bondi holds drug industry accountable for Florida opioid crisis

Editorial: Bondi holds drug industry accountable for Florida opioid crisis

Florida Attorney General Pam Bondi’s lawsuit against the nation’s largest drug makers and distributors marks a moment of awakening in the state’s battle to recover from the opioid crisis. In blunt, forceful language, Bondi accuses these companies of ...
Published: 05/16/18
Updated: 05/18/18
Editorial: Johns Hopkins All Children’s should be more open about mistakes

Editorial: Johns Hopkins All Children’s should be more open about mistakes

A state investigation raises even more concern about medical errors at Johns Hopkins All Children’s Hospital and the venerable St. Petersburg institution’s lack of candor to the community. Regulators have determined the hospital broke Florida law by ...
Published: 05/16/18
Updated: 05/17/18
Editorial: St. Petersburg recycling worth the effort despite cost issues

Editorial: St. Petersburg recycling worth the effort despite cost issues

St. Petersburg’s 3-year-old recycling program has reached an undesirable tipping point, with operating costs exceeding the income from selling the recyclable materials. The shift is driven by falling commodity prices and new policies in China that cu...
Published: 05/15/18
Updated: 05/18/18
Editorial: HUD’s flawed plan to raise rents on poor people

Editorial: HUD’s flawed plan to raise rents on poor people

Housing Secretary Ben Carson has a surefire way to reduce the waiting lists for public housing: Charge more to people who already live there. Hitting a family living in poverty with rent increases of $100 or more a month would force more people onto ...
Published: 05/15/18
Updated: 05/18/18
Editorial: Voters should decide whether legal sports betting comes to Florida

Editorial: Voters should decide whether legal sports betting comes to Florida

It’s a safe bet Florida will get caught up in the frenzy to legalize wagering on sports following the U.S. Supreme Court opinion this week that lifted a federal ban. Struggling horse and dog tracks would love a new line of business, and state l...
Published: 05/15/18
Updated: 05/16/18